Friday, May 18, 2012

Geron founder Dr. Michael West Talks Stem Cells on CNBC

Geron founder Dr. Michael West Talks Stem Cells on CNBC

January 2009: FDA milestone in stem cell research Geron announced that it has received FDA approval to proceed with the first-ever human embryonic stem cell studies. As an accomplished scientist and businessman, and as one of the world’s foremost authorities on embryonic stem cell research, Dr. West discusses the significance of this finding for the biotech industry and for the country as a whole. Unlike many other biotech executives, Dr. West discusses the political ramifications, and prospects for science and medicine under the Obama administration. Dr. West is currently the CEO of BioTime, a biotech company based in Northern California. Dr. West recently issued an open letter to President Barack Obama, signed by over 20 Nobel Laureates, urging repeal of the ban on embryonic stem cell research and development. Dr. Michael West Dr. West is the Chief Executive Officer of BioTime, Inc. and Embryome Sciences, Inc. of Emeryville, California and Adjunct Professor of Bioengineering at the University of California, Berkeley. BioTime, Inc. (OTCBB: BTIM) and its wholly-owned subsidiary Embryome Sciences are companies focused on human embryonic stem cell technologies. He received his Ph.D. from Baylor College of Medicine in 1989 concentrating on the biology of cellular aging. He has focused his academic and business career on the application of developmental biology to the age-related degenerative disease. He was the Founder of Geron Corporation of Menlo Park, California (Nasdaq
Video Rating: 5 / 5

Share and Enjoy:
  • Print
  • Digg
  • Sphinn
  • del.icio.us
  • Facebook
  • Mixx
  • Google Bookmarks
  • Blogplay

Related Stem Cell Articles



2 Comments

  1. Comments  sd62t833   |  Sunday, 29 May 2011 at 9:39 pm

    @sd62t833 “I’ve got problems with that”

    You and everyone else that will be hopping a plane to CHina for stem cell medicine to recover from a stroke or whatever.
    UNLESS companies like Geron are allowed to continue.

  2. Comments  sd62t833   |  Sunday, 29 May 2011 at 10:23 pm

    Let’s hope they continue.

    Otherwise China and Singapore will own that market.

Stem Cell Protocols Methods Main Menu